Hemoptysis
DIFFERENTIAL
DIAGNOSIS
NON
CARDIOPULMONARY epistaxis, upper GI bleed, coagulopathy
CARDIAC HF,
mitral Stenosis
PULMONARY
AIRWAY
bronchitis (acute, chronic), bronchiec tasis, malignancy, foreign body, trauma
PARENCHYMA
MALIGNANCY
lung cancer, metastasis
INFECTIONS
necrotizing pneumonia (Staphy lococcus, Pseudomonas), abscess, septic emboli,
TB, fungal
ALVEOLAR
HEMORRHAGE Wegener’s granuloma tosis, Churg Strauss, Goodpasture disease, pul
monary capillaritis, connective tissue disease
VASCULAR
pulmonary embolism, pulmonary hypertension, AVM, iatrogenic
PATHOPHYSIOLOGY
MASSIVE
HEMOPTYSIS 100 600 mL blood in 24 h. Patients may die of asphyxiation (rather
than exsanguination)
CLINICAL
FEATURES
HISTORY
characterize hemoptysis (amount, fre quency, previous history), cough
(productive), dyspnea, chest pain, epistaxis, hematemesis, weight loss, fever,
night sweats, exposure, travel, joint inflammation, rash, visual changes, past
medical history (smoking, lung cancer, TB, thromboembolic disease, cardiac
disease), medi cations (warfarin, ASA, NSAIDs, natural supplements)
PHYSICAL
vitals, weight loss, clubbing, cyanosis, lymphadenopathy, Horner’s syndrome,
respiratory and cardiac examination, leg swelling (HF or DVT), joint
examination, skin examination
INVESTIGATIONS
BASIC
LABS CBCD,
lytes, urea, Cr, INR, PTT, urinalysis
MICROBIOLOGY
blood C&S, sputum Gram stain/ AFB/fungal/C&S/cytology
IMAGING CXR, CT
chest (warranted in most patients unless obvious explanation)
BRONCHOSCOPY
warranted in most patients unless obvious explanation
SPECIAL
ETIOLOGY WORKUP
ANA, p anca (myeloperoxi dase MPO antibodies), c anca (antiproteinase
3 PR3 antibodies), anti GBM antibody, rheumatologic screen
ABG if
respiratory distress
MANAGEMENT
ACUTE ABC,
O2, IV, intubation to protect airway if significant hemoptysis
SYMPTOM CONTROL
cough suppressants, seda tives, stool softeners. Transfusions. Urgent interven
tional bronchoscopy (topical epinephrine, cold sal ine, cautery). Angiographic
arterial embolization. Lung resection
TREAT
UNDERLYING CAUSE correct coagulopa thy (vitamin K 10 mg SC 1 dose or FFP);
antibiotics; radiation for tumors; diuresis for HF; immunosup pression for
vasculitis
SPECIFIC
ENTITIES
GOODPASTURE
DISEASE
PATHOPHYSIOLOGY
antibasement membrane antibodies ! attack pulmonary and renal base ment
membrane
CLINICAL
FEATURES hemoptysis and hematuria, with respiratory and renal failure if
severe
DIAGNOSIS
lung/kidney biopsy
TREATMENTS
steroids, cyclophosphamide, plasma pheresis
Comments
Post a Comment